Biotechnology Market Report 2022-2030: Industry Growth, Top Companies Share, Size, and Forecast

The Global biotechnology market size was valued at US$ 1,023.93 billion in 2021 and is expected to hit US$ 3,879.52 billion by 2030, growing at a compound annual growth rate (CAGR) of 13.11% from 2022 to 2030.

Artificial Intelligence (AI) in Healthcare Market Size US$ 187.95 Bn by 2030

The global artificial intelligence (AI) in healthcare market size is projected to reach US$ 187.95 billion by 2030 at a steady CAGR of 37% from 2022 to 2030.

Efficacy Testing Market Scope and Technological Advancement 2019 - 2028

The major driving force of the efficacy testing market is the increasing pharmaceutical and biotechnology industry driven by government support and the positive trend in the research and development work in the life science sector.

U.S. Behavioral Health Market Size to Hit USD 132.4 Billion by 2027

According to Precedence Research, the US behavioral health market is predicted to hit around USD 132.4 billion by 2027 from valued at USD 90.5 billion in 2020 and growing at a CAGR of 5.32% between 2021 and 2027.

AI in Drug Discovery Market Size US$ 11.9 Billion by 2030

The AI in drug discovery market size is projected to reach US$ 11.9 billion by 2030 at a steady CAGR of 29.62% from 2022 to 2030.

Ground-breaking New MRI Room Alert for Healthcare’s Most Dangerous Room.

BRIM Biotechnology enters OTC trading in Taiwan

BRIM Biotechnology, Inc. (BRIM, TWSE 6885) entered OTC trading in Taiwan on 23rd June 2022, CST. The news was announced at the company’s first earnings call on 22nd June 2022.

CRISPR Genome Editing Market Potential Growth, Top Companies Analysis and Segment Forecasts, 2019 - 2028

The CRISPR genome editing market is classified into by applications, end-user, and geography.

Flywheel Launches New Products to Accelerate Clinical Research and Clinical Trials Data Management

Flywheel, the leading data management platform for biomedical research and collaboration, is adding two new solutions to its product suite. Flywheel Trial Flow and Flywheel Discovery will give researchers new ways to streamline clinical trials, plus discover patient cohorts and analyze data on an enterprise scale.

Cytiva expanding US operations beyond the East Coast

Sharp expands clinical services operations at its EU Heerenveen facility

About Sharp Sharp is a global leader in clinical supply chain services and pharmaceutical packaging. For more than 65 years, we’ve provided solutions to pharma and biotech clients from phase I trials through to commercial launch and lifecycle management. With facilities in the United States, United Kingdom, Belgium and the Netherlands and 30+ clinical depots globally, covering every region of the world, we are engineered to deliver. Through our partnership with Berkshire Sterile Manufacturing we offer specialist isolator-based filling of vials, syringes, cartridges and containers, as well as lyophilization and terminal sterilization. Our full complement of integrated services includes: research and development, clinical manufacturing, primary and secondary packaging of both investigational and commercial product, package design, serialization and aggregation, storage and distribution and clinical IRT. Sharp also offers Qualified Person (QP) services to meet the complex regulatory demands of the EU and UK.

Connect in Pharma launches art exhibition and charity partnership to raise funds for rare disease research

The organisers of Connect in Pharma announce today that for every visitor to the Geneva-based event, five Swiss francs will be donated to EspeRare Foundation, a not-for-profit organisation that identifies, develops and promotes access to life-changing treatments and technologies for patients affected by rare diseases.

Bioprocess Containers Market Global Industry Insights, Size and Share 2019 to 2028

The bioprocess containers market is segmented based on by type, by application, by end user and by geography.

Discovery Life Sciences Acquires AllCells

The global gene therapy market is expected to grow to $5.02B by 2028. It’s slated to be the fastest growing investive market in the world over the next 5 years. Helping fuel this growth, Discovery Life Sciences, the biospecimen and biomarker specialists, has acquired AllCells, a leading provider of clinical-grade (GMP-compliant) and Research Use Only primary cell products. With more than 30 years of joint cell and gene therapy experience, the two companies' combined solutions will: Establish the premier provider for critical starting materials and analytic services to accelerate CGT applications Create one of the industry's largest dedicated client donor pools Provide a “one-stop-shop” for revolutionary products and services with greater speed and reliability to satisfy the entire CGT continuum Offer continuity for every stage of development, spanning RUO and GMP grade fresh, cryopreserved, and mobilized leukoplaks, as well as immune cell isolations, diseased biospecimens, and expert analytical service Effective immediately, AllCells CEO and President Danny Zheng will lead the combined entity. I’m happy to set up an interview with him to discuss the news in further detail. Thank you and please feel free to reach out with questions -

Global Precision Medicine Software Market is projected to witness a healthy growth rate of 10% in the upcoming years

The global precision medicine software market is driven by growing research in genomics/precision medicine, significant VC fundings, rising government support and the rapid shift toward personalized treatments.

BioIVT Launches New Scientific Advisory Board

Its new Board members will provide expert insight into ADME-Tox, biomarker, assay, cell and gene therapy, and immuno-oncology advances.

Cotiviti’s Quality Intelligence Earns NCQA Certified Measures Status for the 2022 Measurement Year

22nd consecutive year that Cotiviti’s solution has passed rigorous NCQA review process

3DR Labs Introduces New Imaging Services to Meet Specific Radiology Market Needs

Its new Cardiac Center of Excellence and Imaging Excellence Advisory Services are designed to support radiology departments nationwide.

Celegence adds report writing functionality to EU MDR & IVDR compliance technology CAPTIS™ to help streamline medical writing and document maintenance

Celegence, a global provider of regulatory affairs services and solutions for the life sciences industry, has today announced the addition of new features to CAPTIS™ to help the device and diagnostic industry produce compliant Post Market Surveillance (PMS) documentation more efficiently.

Analytical Standards Market Size, Technique, and Forecast to 2028

Global analytical standards market is analysed based on product, technique, methodology, category and geography.